Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022
April 25, 2022
Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022
April 25, 2022
Beyond Air® to Participate in Three Upcoming Medical Conferences
April 18, 2022
Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect
April 11, 2022
Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting
March 8, 2022
Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022
February 10, 2022
Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022
February 8, 2022
Beyond Air® Announces Two Appointments to Beyond Cancer™ Board of Directors
February 3, 2022
Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast
January 27, 2022
Beyond Air® Provides Regulatory Update for LungFit® PH
December 9, 2021

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe